Xylem Inc. XYL SPXR3K
Company Overview
Xylem Inc., together with its subsidiaries, engages in the design, manufacture, and servicing of engineered products and solutions for utility, industrial, and residential and commercial building services settings worldwide. It operates through Water Infrastructure; Applied Water; Measurement and Control Solutions; and Water Solutions and Services segments. The company offers water, wastewater, and storm water pumps and controls and systems; filtration, disinfection, and biological treatment equipment under the Flygt, Ionpure, Leopold, Neptune Benson, Sanitare, Wallace & Tiernan, and Wedeco brands; and pumps, valves, heat exchangers, controls, and dispensing equipment used for water and focuses on the residential, commercial and industrial markets under the Rule, Bell & Gossett, Flojet, Goulds Water Technology, Jabsco, and Lowara brands. It also provides smart meters, network communication devices, data analytics, test instruments, controls, sensor devices, software and managed services, critical infrastructure services, cloud-based analytics, and remote monitoring and data management under the Ebro, Sensus, Sentec, Smith Blair, WTW, YSI, and Xylem Vue brands. In addition, the company offers preventative maintenance services, rapid response mobile services, digitally enabled/outsourced solutions, process and wastewater treatment systems, environmental remediation, odor and corrosion control, filtration, reverse osmosis, continuous deionization, and mobile dewatering equipment and rental services; and municipal services comprising odor and corrosion control services, as well as condition assessment and asset management, and pressure monitoring solutions under the Grindex, Mar Cor, and Godwin brands. Xylem Inc. was formerly known as ITT WCO, Inc. and changed its name to Xylem Inc. in July 2011. The company was incorporated in 2011 and is headquartered in Washington, District Of Columbia.
Why Investors Should Care
Trades at a P/E of 25.2, below the sector median of 27.4.
Operating margin of 17.0% supports profitability.
Carries low leverage with a debt-to-equity ratio of 0.29.
Generates positive free cash flow, funding growth and shareholder returns internally.
Recent Developments
- Dec 2025 Revenue of $9.04B (+5.5% YoY); net profit $957.00M.
- Trailing 12 Months Year-on-year growth — revenue +1.5%, earnings +19.5%.
- 5-Year Trend Long-term compounding — revenue CAGR 8.0%, profit CAGR 8.4%.
Growth & Price Performance
Compounded Sales Growth
| 5 Years: | 8.00% |
| 1 Year: | 1.50% |
Compounded Profit Growth
| 5 Years: | 8.41% |
| 1 Year: | 19.50% |
Stock Price Performance
| 1 Year: | -25.41% |
| 6 Months: | -13.51% |
| 3 Months: | -3.50% |
| 1 Month: | -12.15% |
Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.
- Price vs 50-DMABelow
- Price vs 200-DMABelow
- RSI (14)30.28 · Neutral
P/E of 25.16 is below the sector median of 27.38 — relatively cheaper than peers.
Auto-generated from price history and fundamentals; not investment advice.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth Charts
No fundamental data available for this stock.
Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.
PROS
- Generates positive free cash flow.
CONS
- Trading 29.9% below its 52-week high.
- In a downtrend (50-DMA below 200-DMA).
* The pros and cons are auto-generated from financial metrics.
Valuation
Growth (CAGR)
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Peer comparison
Peer companies in the same sector (Industrials).
| # | Name | CMP $ | P/E | Mkt Cap | Div Yld % | ROCE % | ROE % | Rev CAGR 5Y % | Profit CAGR 5Y % |
|---|---|---|---|---|---|---|---|---|---|
| 1 | XYL Xylem Inc. SPXR3K | 105.69 | 25.16 | $24.68B | 1.42% | 8.97% | 9.18% | 8.00% | 8.41% |
| 2 | SPCX Space Exploration Technologies Corp. R3KAIDEFENCE | 147.95 | -134.50 | $1.12T | 0.00% | -3.22% | -11.95% | 34.08% | -3.34% |
| 3 | CAT Caterpillar Inc. SPXR3K | 813.94 | 35.05 | $374.15B | 0.76% | 17.98% | 56.97% | 2.29% | 5.24% |
| 4 | GE GE Aerospace SPXR3KDEFENCE | 337.12 | 39.85 | $349.78B | 0.50% | 9.52% | 48.23% | -7.42% | -5.36% |
| 5 | RTX RTX Corporation SPXR3KDEFENCE | 200.79 | 35.41 | $270.62B | 1.31% | 8.28% | 12.27% | 2.61% | 2.62% |
| 6 | GEV GE Vernova Inc. SPXR3KAI | 941.95 | 26.98 | $250.87B | 0.20% | 6.30% | 82.58% | 8.68% | - |
| 7 | DE Deere & Company SPXR3K | 693.53 | 39.29 | $187.33B | 1.05% | 12.53% | 18.35% | 3.43% | 5.10% |
| 8 | UNP Union Pacific Corporation SPXR3K | 291.88 | 23.83 | $173.40B | 1.92% | 15.22% | 39.70% | 2.30% | 7.77% |
| 9 | BA The Boeing Company SPXR3KDEFENCE | 212.25 | 76.08 | $167.63B | 0.00% | -9.01% | - | 1.67% | -3.28% |
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios
Quarterly Results
Figures in USD.
| Metric | Dec 2015 | Mar 2016 | Jun 2016 | Sep 2016 | Dec 2016 | Mar 2017 | Jun 2017 | Sep 2017 | Dec 2017 | Mar 2018 | Jun 2018 | Sep 2018 | Dec 2018 | Mar 2019 | Jun 2019 | Sep 2019 | Dec 2019 | Mar 2020 | Jun 2020 | Sep 2020 | Dec 2020 | Mar 2021 | Jun 2021 | Sep 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.38B | 1.45B | 1.72B | 2.08B | 2.03B | 2.17B | 2.10B | - | 2.07B | 2.30B | 2.27B | 2.40B | 2.12B | 2.34B |
| Cost of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.30B | 1.41B | 1.39B | 1.47B | 1.32B | - |
| Gross Profit | 390.00M | 329.00M | 369.00M | 357.00M | 406.00M | 412.00M | 457.00M | 471.00M | 507.00M | 460.00M | 519.00M | 505.00M | 542.00M | 474.00M | 526.00M | 509.00M | 537.00M | 409.00M | 434.00M | 461.00M | 526.00M | 490.00M | 520.00M | 472.00M | 467.00M | 520.00M | 524.00M | 546.00M | 651.00M | 764.00M | 752.00M | 819.00M | 784.00M | - | 768.00M | 892.00M | 883.00M | 932.00M | 803.00M | 963.00M |
| Operating Expenses | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 516.00M | 561.00M | 526.00M | 546.00M | 528.00M | - |
| Operating Income | 142.00M | 79.00M | 109.00M | 109.00M | 109.00M | 86.00M | 137.00M | 152.00M | 177.00M | 113.00M | 171.00M | 176.00M | 194.00M | 109.00M | 171.00M | 11.00M | 195.00M | 61.00M | 54.00M | 73.00M | 179.00M | 133.00M | 160.00M | 152.00M | 111.00M | 146.00M | 168.00M | 131.00M | 119.00M | 191.00M | 209.00M | 253.00M | 280.00M | - | 252.00M | 331.00M | 357.00M | 386.00M | 275.00M | 390.00M |
| EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 370.00M | 453.00M | 445.00M | 517.00M | 388.00M | - |
| Interest Expense | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 8.00M | 9.00M | 6.00M | 6.00M | 4.00M | - |
| Pretax Income | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 217.00M | 299.00M | 297.00M | 368.00M | 244.00M | - |
| Tax Provision | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 50.00M | 75.00M | 71.00M | 35.00M | 55.00M | - |
| Net Income | 114.00M | 66.00M | 71.00M | 73.00M | 50.00M | 56.00M | 99.00M | 105.00M | 71.00M | 79.00M | 115.00M | 130.00M | 225.00M | 79.00M | 139.00M | 65.00M | 118.00M | 38.00M | 31.00M | 37.00M | 148.00M | 87.00M | 113.00M | 114.00M | 82.00M | 112.00M | 12.00M | 99.00M | 92.00M | 152.00M | 153.00M | 194.00M | 217.00M | - | 169.00M | 226.00M | 227.00M | 335.00M | 193.00M | 263.00M |
| Diluted EPS | 0.63 | 0.37 | 0.39 | 0.41 | 0.28 | 0.31 | 0.55 | 0.58 | 0.40 | 0.43 | 0.64 | 0.72 | 1.24 | 0.43 | 0.77 | 0.36 | 0.65 | 0.21 | 0.17 | 0.20 | 0.82 | 0.48 | 0.62 | 0.63 | 0.45 | 0.62 | 0.07 | 0.54 | 0.45 | 0.63 | 0.63 | 0.80 | 0.89 | - | 0.69 | 0.93 | 0.93 | - | 0.79 | 1.11 |
| R&D Expense | - | 25.00M | 27.00M | 23.00M | - | 42.00M | 44.00M | 45.00M | - | 41.00M | 50.00M | 46.00M | - | 51.00M | 47.00M | 44.00M | - | 49.00M | 44.00M | 45.00M | - | 50.00M | 53.00M | 49.00M | 52.00M | 53.00M | 47.00M | 53.00M | 58.00M | 61.00M | 59.00M | 58.00M | 55.00M | - | 56.00M | 58.00M | 52.00M | - | 56.00M | 59.00M |
Profit & Loss (Annual)
Figures in USD.
| Metric | Dec 2009 | Dec 2010 | Oct 2011 | Dec 2011 | Dec 2012 | Dec 2013 | Dec 2014 | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 2.85B | 3.20B | - | 3.80B | 3.79B | 3.84B | 3.92B | 3.65B | 3.77B | 4.71B | 5.21B | 5.25B | 4.88B | - | 5.52B | 7.36B | 8.56B | 9.04B |
| Cost of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 3.44B | 4.65B | 5.35B | 5.56B |
| Gross Profit | 1.04B | 1.21B | - | 1.46B | 1.50B | 1.50B | 1.51B | 1.40B | 1.46B | 1.85B | 2.03B | 2.05B | 1.83B | - | 2.08B | 2.72B | 3.21B | 3.48B |
| Operating Expenses | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.43B | 1.99B | 2.14B | 2.15B |
| Operating Income | 276.00M | 388.00M | - | 395.00M | 443.00M | 363.00M | 463.00M | 449.00M | 408.00M | 552.00M | 654.00M | 486.00M | 367.00M | - | 651.00M | 728.00M | 1.07B | 1.33B |
| EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 726.00M | 1.12B | 1.69B | 1.78B |
| Interest Expense | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 50.00M | 49.00M | 44.00M | 29.00M |
| Pretax Income | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 440.00M | 635.00M | 1.09B | 1.18B |
| Tax Provision | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 85.00M | 26.00M | 197.00M | 231.00M |
| Net Income | 263.00M | 329.00M | 220.00M | 279.00M | 297.00M | 228.00M | 337.00M | 340.00M | 260.00M | 331.00M | 549.00M | 401.00M | 254.00M | - | 355.00M | 609.00M | 890.00M | 957.00M |
| Diluted EPS | 1.42 | 1.78 | - | 1.50 | 1.59 | 1.22 | 1.83 | 1.87 | 1.45 | 1.83 | 3.03 | 2.21 | 1.40 | - | 1.96 | 2.79 | 3.65 | 3.92 |
| R&D Expense | 63.00M | 74.00M | - | 100.00M | 106.00M | 104.00M | 104.00M | 95.00M | 110.00M | 181.00M | 189.00M | 191.00M | 187.00M | 204.00M | 206.00M | 232.00M | 230.00M | 226.00M |
Balance Sheet (Annual)
Figures in USD.
| Metric | Dec 2008 | Dec 2009 | Dec 2010 | Dec 2011 | Dec 2012 | Dec 2013 | Dec 2014 | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | - | - | 3.73B | 4.40B | 4.68B | 4.86B | 4.83B | 4.66B | 6.47B | 6.86B | 7.22B | 7.71B | 8.75B | - | 7.95B | 16.11B | 16.49B | 17.63B |
| Current Assets | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 3.01B | 3.88B | 4.10B | 4.64B |
| Cash & Equivalents | 81.00M | 131.00M | 131.00M | 318.00M | 504.00M | 533.00M | 663.00M | 680.00M | 308.00M | 414.00M | 296.00M | 724.00M | 1.88B | - | 944.00M | 1.02B | 1.12B | 1.48B |
| Inventory | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 799.00M | 1.02B | 996.00M | 983.00M |
| Receivables | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.10B | 1.62B | 1.67B | 1.76B |
| Total Liabilities | - | - | 1.02B | 2.57B | 2.60B | 2.65B | 2.71B | 2.57B | 4.27B | 4.34B | 4.44B | 4.74B | 5.77B | - | 4.45B | 5.94B | 5.61B | 5.88B |
| Current Liabilities | - | - | 649.00M | 817.00M | 781.00M | 853.00M | 903.00M | 823.00M | 1.24B | 1.10B | 1.39B | 1.50B | 1.96B | - | 1.59B | 2.21B | 2.34B | 2.86B |
| Long Term Debt | - | - | 4.00M | 1.20B | 1.20B | 1.20B | 1.20B | 1.20B | 2.11B | 2.20B | 2.05B | 2.04B | 2.48B | - | 1.88B | 2.27B | 1.98B | 1.41B |
| Total Debt | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.95B | 2.39B | 2.12B | 2.06B |
| Total Equity | 1.64B | 1.69B | 2.72B | 1.83B | 2.07B | 2.24B | 2.13B | 2.08B | 2.19B | 2.50B | 2.77B | 2.96B | 2.97B | - | 3.49B | 10.17B | 10.64B | 11.48B |
| Shares Outstanding | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 196.00M | 257.60M | 259.20M | 259.88M |
Cash Flows (Annual)
Figures in USD.
| Metric | Dec 2009 | Dec 2010 | Dec 2011 | Dec 2012 | Dec 2013 | Dec 2014 | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | 370.00M | 395.00M | 449.00M | 396.00M | 324.00M | 416.00M | 464.00M | 497.00M | 686.00M | 586.00M | 839.00M | 824.00M | - | 596.00M | 837.00M | 1.26B | 1.24B |
| Investing Cash Flow | -84.00M | -1.09B | -423.00M | -147.00M | -199.00M | -86.00M | -132.00M | -1.89B | -181.00M | -643.00M | -231.00M | -169.00M | - | -191.00M | -628.00M | -482.00M | -471.00M |
| Financing Cash Flow | -292.00M | 745.00M | 172.00M | -74.00M | -100.00M | -147.00M | -262.00M | 1.03B | -421.00M | -40.00M | -177.00M | 473.00M | - | -790.00M | -157.00M | -615.00M | -501.00M |
| Capital Expenditure | - | - | - | - | - | - | - | - | - | - | - | - | - | -208.00M | -271.00M | -321.00M | -331.00M |
| Free Cash Flow | - | - | - | - | - | - | - | - | - | - | - | - | - | 388.00M | 566.00M | 942.00M | 910.00M |
| Net Change in Cash | - | - | - | - | - | - | - | - | - | - | - | - | - | -385.00M | 52.00M | 166.00M | 269.00M |
| Share Buybacks | - | 0 | 0 | 13.00M | 73.00M | 134.00M | 179.00M | 4.00M | 25.00M | 59.00M | 40.00M | 61.00M | 68.00M | 52.00M | 25.00M | 20.00M | 15.00M |
Ratios (Annual)
Figures in %.
| Metric | Dec 2009 | Dec 2010 | Oct 2011 | Dec 2011 | Dec 2012 | Dec 2013 | Dec 2014 | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin % | 36.4% | 37.9% | - | 38.4% | 39.6% | 39.1% | 38.6% | 38.4% | 38.8% | 39.2% | 38.9% | 39.0% | 37.5% | - | 37.7% | 36.9% | 37.5% | 38.5% |
| Operating Margin % | 9.7% | 12.1% | - | 10.4% | 11.7% | 9.5% | 11.8% | 12.3% | 10.8% | 11.7% | 12.6% | 9.3% | 7.5% | - | 11.8% | 9.9% | 12.5% | 14.7% |
| Net Margin % | 9.2% | 10.3% | - | 7.3% | 7.8% | 5.9% | 8.6% | 9.3% | 6.9% | 7.0% | 10.5% | 7.6% | 5.2% | - | 6.4% | 8.3% | 10.4% | 10.6% |
| ROE % | 15.6% | 12.1% | - | 15.2% | 14.3% | 10.2% | 15.8% | 16.3% | 11.9% | 13.2% | 19.8% | 13.6% | 8.6% | - | 10.2% | 6.0% | 8.4% | 8.3% |
| ROCE % | - | 12.6% | - | 11.0% | 11.4% | 9.1% | 11.8% | 11.7% | 7.8% | 9.6% | 11.2% | 7.8% | 5.4% | - | 10.2% | 5.2% | 7.6% | 9.0% |
Shareholding Pattern
Top Institutional Holders
| # | Holder | % Held | Shares | Value |
|---|---|---|---|---|
| 1 | Blackrock Inc. | 10.72% | 25.04M | $2.79B |
| 2 | Vanguard Capital Management LLC | 6.65% | 15.53M | $1.73B |
| 3 | Vanguard Portfolio Management LLC | 5.40% | 12.62M | $1.40B |
| 4 | State Street Corporation | 4.90% | 11.44M | $1.27B |
| 5 | Geode Capital Management, LLC | 2.72% | 6.35M | $706.57M |
| 6 | Amundi | 2.19% | 5.11M | $568.27M |
| 7 | Invesco Ltd. | 2.19% | 5.10M | $567.91M |
| 8 | Bank Of New York Mellon Corporation | 2.00% | 4.67M | $520.07M |
| 9 | Royal Bank of Canada | 1.97% | 4.61M | $512.60M |
| 10 | Impax Asset Management Group plc | 1.91% | 4.47M | $497.44M |
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for XYL
Europe Pump Market Research Report 2026-2031 Now Available, Forecasts Market Growth from $17.5B (2025) to $22.53B by 2031, Profiling Grundfos, Xylem, Ebara, Wilo, Flowserve, and 55 Other Key Players
The Europe pump market was valued at USD 17.50 billion in 2025 and is forecast to reach USD 22.53 billion by 2031, growing at a 4.30% CAGR. Electrical pumps lead with a 62% share, while centrifugal pumps dominate by product and single-stage…
Xylem (XYL) Down 7.1% Since Last Earnings Report: Can It Rebound?
Xylem (XYL) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Xylem (XYL) Could Be 23% Below Fair Value Following Its Q2 Profit Outlook Lift
Xylem (XYL) is back in focus after its Q2 FY2026 results showed stronger profitability. The company raised adjusted EPS guidance and improved its adjusted EBITDA margin outlook, despite trimming its full year revenue forecast. See our lates…
What Should Xylem (XYL) Investors Make Of Its New CFO And Board Pick?
Xylem (NYSE:XYL) appointed Andrea van der Berg as Chief Financial Officer and Executive Vice President. The company also added D. Christian Koch to its Board of Directors. These leadership changes highlight a refreshed focus on financial ov…
GE HealthCare names new CFO
William Grogan will take over the chief finance job vacated by Jay Saccaro. Stifel analysts called Grogan’s “no-nonsense” mindset on setting expectations a strength.
Xylem Stock: Analyst Estimates & Ratings
Xylem has underperformed the broader market, while analysts remain moderately optimistic about its future prospects.
XYL — Frequently Asked Questions
What is the current share price of Xylem Inc. (XYL)?
As of 2026-09-07 16:24 PDT, Xylem Inc. (XYL) trades at $105.69 on NYSE. Its 52-week range is $105.52 to $150.84.
What is the market capitalisation of XYL?
Xylem Inc. (XYL) has a market capitalisation of $24.68B on NYSE.
What is the P/E ratio of XYL?
XYL trades at a trailing price-to-earnings (P/E) ratio of 25.16. The industry average P/E is 27.38. Its price-to-book (P/B) ratio is 2.55.
Does XYL pay a dividend?
Xylem Inc. (XYL) currently offers a dividend yield of 1.42%.
What is the return on equity (ROE) of XYL?
XYL has a return on equity (ROE) of 9.18%. Its return on capital employed (ROCE) is 8.97%.
Is XYL a good stock to buy?
This page provides a data-driven analysis of Xylem Inc. (XYL), including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.